Menu

Press Releases

Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results

, , , ,

SPIRE-HR and SPIRE-FH trials met primary endpoints in patients at high and very high risk for cardiovascular events June 28, 2016 – Pfizer Inc. announced two additional Phase 3 bococizumab trials, SPIRE-HR (HighRisk) and SPIRE-FH (Familial Hypercholesterolemia), met their primary endpoint, demonstrating a significant reduction in the percent change from baseline in low-density lipoprotein cholesterol […]

MDLIVE Expands Behavioral Health Services with Free Online Assessments and Advice for Common Behavioral Issues

,

Company launches new tools to evaluate stress, relationship problems, and more. Sunrise, Florida, June 10, 2016 — MDLIVE, the nation’s leader in the rapidly growing virtual health market, today announced the launch of several new tools designed to help individuals evaluate their behavioral health needs. The company’s teletherapy services are offered through Breakthrough, an MDLIVE […]

FDA approves first buprenorphine implant for treatment of opioid dependence

,

Expanded use and availability of medication-assisted treatment is a top priority of federal effort to combat opioid epidemic May 26, 2016 – The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in […]

Larry Gleit Named General Manager for MDLIVE/Behavioral Health and Breakthrough, an MDLIVE Company

,

SUNRISE, Florida, May 20, 2016 — MDLIVE, the nation’s leader in the rapidly growing virtual health market, today announced that Larry Gleit has been named general manager for MDLIVE/Behavioral Health and Breakthrough, an MDLIVE company, effective immediately. “Larry Gleit has the experience and expertise to lead our teletherapy business forward as we expand our capabilities […]

Tom Barone Named President and Chief Operating Officer of MDLIVE

,

SUNRISE, Fla., May 20, 2016 — MDLIVE, the nation’s leader in the rapidly growing virtual health market, today announced that Tom Barone has been appointed president and chief operating officer. Barone brings more than 20 years of operations, supply chain, client service, business development, call center, eCommerce and executive leadership experience to MDLIVE from companies […]

Edwards SAPIEN 3 TAVR Demonstrates Clinical Superiority To Surgery In PARTNER II Study

, , , ,

Trial Studied Severe, Symptomatic Aortic Stenosis Patients at Intermediate Risk for Surgery CHICAGO, April 3, 2016 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that new data on patients at intermediate risk for open-heart surgery demonstrated that transcatheter aortic valve replacement […]

Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial

, , , ,

CHICAGO, April 2, 2016 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the randomized PARTNER II Trial comparing the SAPIEN XT valve to surgery in intermediate-risk patients successfully achieved its primary endpoint at two years. The results of the study […]

Merck Receives 2016 ENERGY STAR Sustained Excellence Award From U.S. Environmental Protection Agency

, ,

Company Receives EPA Honor for 11th Consecutive Year April 1, 2016 – KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2016 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued improvement of […]

Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics

, , ,

Pivotal RA-BEACON Study Published in New England Journal of Medicine INDIANAPOLIS, March 31, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that detailed results of RA-BEACON — a pivotal phase 3 global study of baricitinib, a once-daily oral treatment currently under regulatory review for the treatment of moderate-to-severe […]

Merck to Present New Findings from Chronic Hepatitis C Clinical Development Programs at The International Liver CongressTM 2016

, , , ,

Presentations Include Results from Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) Compared to Sofosbuvir-Containing Regimen, and Results from Studies in Difficult-to-Treat Populations March 30, 2016 – KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the planned presentations of data from the company’s broad chronic hepatitis C […]

«‹ 75 76 77 78›»